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Background: Cytoskeletal proteins are often involved in the virus life cycle, either at early steps during virus entry
or at later steps during formation of new virus particles. Though actin filaments have been shown to play a role in
the production of measles virus (MV), the importance of actin dynamics for virus assembly and budding steps is not
known yet. Aim of this work was thus to analyze the distinctive consequences of F-actin stabilization or disruption
for MV protein trafficking, particle assembly and virus release.
Results: MV infection studies in the presence of inhibitors differently affecting the actin cytoskeleton revealed that
not only actin disruption but also stabilization of actin filaments interfered with MV particle release. While overall
viral protein synthesis, surface expression levels of the MV glycoproteins, and cell-associated infectivity was not
altered, cell-free virus titers were decreased. Interestingly, the underlying mechanisms of interference with late MV
maturation steps differed principally after F-actin disruption by Cytochalasin D (CD) and F-actin stabilization by
Jasplakinolide (Jaspla). While intact actin filaments were shown to be required for transport of nucleocapsids and
matrix proteins (M-RNPs) from inclusions to the plasma membrane, actin dynamics at the cytocortex that are
blocked by Jaspla are necessary for final steps in virus assembly, in particular for the formation of viral buds and the
pinching-off at the plasma membrane. Supporting our finding that F-actin disruption blocks M-RNP transport to the
plasma membrane, cell-to-cell spread of MV infection was enhanced upon CD treatment. Due to the lack of
M-glycoprotein-interactions at the cell surface, M-mediated fusion downregulation was hindered and a more rapid
syncytia formation was observed.
Conclusion: While stable actin filaments are needed for intracellular trafficking of viral RNPs to the plasma
membrane, and consequently for assembly at the cell surface and prevention of an overexerted fusion by the viral
surface glycoproteins, actin dynamics are required for the final steps of budding at the plasma membrane.
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Measles virus (MV) is a prototype member of the Morbilli-
virus genus in the family Paramyxoviridae. In virus parti-
cles, the negative-stranded RNA genome is encapsidated
by the N, P and L proteins, and this ribonucleocapsid
(RNP) is surrounded by a lipid bilayer. The two surface
glycoproteins, the hemagglutinin H and the fusion protein
F, protrude from the viral envelope. The matrix protein
(M) is located at the inner surface of the lipid bilayer* Correspondence: maisner@staff.uni-marburg.de
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reproduction in any medium, provided the ortethering the RNP to the envelope. Due to its interaction
with the glycoproteins and the RNPs, the M protein is es-
sential for MV assembly and particle formation. M binding
to the cytoplasmic tails of the glycoproteins at the surface
of infected cells is furthermore required to downregulate
H/F-mediated cell-to-cell fusion of infected and neighbor-
ing uninfected cells [1-5].
The actin network is primarily associated with mechan-
ical stability, cell motility and cell contraction. It is also
important for chromosome movement during mitosis and
for internal transport, particularly near the plasma
membrane. Cargos can be transported either by riding on
myosin motors along actin filaments or by pushingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Cytoskeletal actin not only has a central function in cell
physiology but is also an essential component involved in
the replication of many RNA and DNA viruses. The mo-
lecular mechanisms underlying this important host-virus
interaction, however, are extremely diverse [7]. For MV,
several reports have shown that actin is involved in virus
maturation at the plasma membrane. This idea was ini-
tially based on the findings that actin was identified as an
internal component of MV particles [8,9] and co-caps with
MV H on infected cells [10]. There is further ultrastruc-
tural evidence that actin filaments take part in the process
of budding and protrude into viral buds [7,8]. Very re-
cently, it was furthermore proposed that F-actin associates
with the MV M protein altering the interaction between
M and H, hereby modulating MV cell-cell fusion and as-
sembly [11].
Though there is conclusive evidence that intact actin fil-
aments are important for MV replication, it is not yet de-
fined if a stable actin cytoskeleton is sufficient, or if actin
dynamics are required. Aim of this study was thus to
analyze the effects of actin-disrupting and actin-stabilizing
drugs to define if actin filaments as structural components
or rather actin dynamics and treadmilling are essential for
MV maturation. Actin treadmilling is a process in which
actin filament length remains approximately constant but
actin monomers preferentially join with the barbed ends
and dissociate from the pointed ends of filaments. This
oriented renewal of actin within microfilaments causes a
treadmilling involving both, actin monomers and actin-
binding proteins. Jasplakinolide (Jaspla) is a cyclic peptide
isolated from a marine sponge that binds to and stabilizes
filamentous actin, inducing a blockade of actin tread-
milling [12,13]. In contrast to Jaspla, Cytochalasin D (CD),
a fungal metabolite, serves as an actin capping compound
that binds to the barbed (+) end of actin filaments and
shifts the polymerization-depolymerization equilibrium
towards depolymerization of F-actin [14].
With our studies on MV replication in the presence of
CD and Jaspla, we show that defects in actin polymerisa-
tion and defects in actin depolymerisation can both inter-
fere with late virus assembly and budding steps without
impairing overall viral protein synthesis, cell-associated in-
fectivity or the surface transport of the MV glycoproteins.
Most interestingly, the underlying mechanism of interfer-
ence with late MV maturation steps by CD and Jaspla dif-
fers principally. While intact actin filaments that can be
disrupted by CD treatment are required for M-RNP
cotransport from the cytoplasm to the plasma membrane,
actin dynamics at the cytocortex blocked by Jaspla are ne-
cessary for later steps in virus maturation at the plasma
membrane. Supporting our finding that actin disruption
blocks M-RNP transport to the plasma membrane, cell-to
-cell spread of MV infection was enhanced upon CDtreatment. Due to the lack of M-glycoprotein-interaction
at the cell surface, M-mediated fusion downregulation is
hindered and a more rapid syncytia formation is observed
in CD-treated cells.
Results
Actin disruption and stabilization affect virus release
without influencing the amount of cell-associated
infectivity
To analyze the importance of the actin polymerization
and depolymerization on MV infection, we quantitated
the release of infectious MV particles and the cell-
associated infectivity in the absence and presence of
4 μM Cytochalasin D (CD) or 100 nM Jasplakinolide
(Jaspla). To visualize the effect and the specificity of
the two inhibitors, actin filaments and microtubules in
non-infected cells treated with CD or Jaspla were either
stained with Phalloidin-FITC or with an anti-tubulin
antibody and an AlexaFluor (AF)488-labelled secondary
antibody, respectively. Actin stress fibers and sub-
cortical actin were readily stained in control cells
(Figure 1A). As CD causes actin disruption by binding
to the barbed plus ends of actin filaments, treatment
with 4 μM CD led to the disappearance of stress fibers
and the actin-dense cytocortex. Actin was rather found
in punctate structures. In contrast to CD, the effect of
the actin filament stabilizing drug Jaspla was evident by
the formation of perinuclear F-actin aggresomes [15]
(Figure 1A). None of the inhibitors affected the fila-
mentous structure of microtubules (Figure 1B) demon-
strating that their effect was specific for actin and not
due to a general breakdown of the cell cytoskeleton. To
exclude that cytotoxic effects due to inhibitor treatment
affect the analyses, cell viability was tested at 48 h p.i.
by incubating live cells with propidium iodide (PI), a
membrane impermeant DNA dye, followed by cell per-
meabilization and nuclear DAPI staining. Control and
inhibitor treated cells were negative for PI staining,
confirming that the cells were viable and that the
plasma membrane was still intact (data not shown). To
monitor MV infection in the presence of the inhibitors,
MDCK cells were infected with MV at an MOI of 10.
At 12 h p.i., inhibitors were added and the cells were
further incubated up to 72 h p.i.. Aliquots from the cell
supernatants were taken every 12 h to determine the
cell-free virus titers. To determine the cell-associated
infectivity, cell lysates were prepared by one freeze-
thaw cycle and were titrated by plaque assay on conflu-
ent Vero cells. Cell disruption by freezing and thawing
allows isolation of intracellular viral RNPs not yet fi-
nally assembled or budding at the plasma membrane.
Figure 2 shows that this cell-associated infectivity was
not reduced by CD or Jaspla treatment suggesting that













Figure 1 Influence of F-actin disruption and stabilization on the actin cytoskeleton and microtubules. MDCK cells were incubated with
the inhibitors (+CD, +Jaspla) which were added at 12 h after seeding. (A) For actin staining at 48h p.s., cells were fixed with PFA and
permeabilized with Triton X-100. F-actin was detected by phalloidin-FITC. Images were obtained using a confocal laser scanning microscope
(Zeiss LSM510). Lower panels show higher magnification of the boxed areas in upper panels. (B) For microtubule staining at 48 h p.s., cells were
fixed with methanol/acetone and incubated with a monoclonal anti-α-tubulin antibody and fluorophore-conjugated secondary antibodies.
Images were obtained using a fluoresence microscope (Zeiss Axiovert 200 M). Bars 10 μm.
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RNPs and viral proteins. In contrast, virus titers in the
supernatants were clearly reduced. In CD- and Jaspla-
treated cells, virus release at 48 h p.i. was reduced by
99% (2 log steps) and 80% (1 log step), respectively. A
similar reduction of virus release by CD and Jaspla
treatment was observed in Vero cells (data not shown).
In agreement with the described reversibility of the
actin inhibitors, the effects of the inhibtors on the pro-
duction of viruses were reversible. When we removed
the inhibitors at 48 h p.i., final virus titers almost
reached control levels within 24 h. While control cells
released 5.1×105 p.f.u./ml between 48 and 72 h p.i.,
virus yield produced between the time of CD and Jaspla
removal and 72 h p.i. increased up to 1.7×105 p.f.u./ml
and 3.5×105 p.f.u./ml, respectively.Viral protein expression is not altered upon inhibitor
treatment
To determine if the reduced virus release upon CD and
Jaspla treatment is due to an overall change in viral pro-
tein expression levels or an altered surface expression
of the viral glycoproteins, MV-infected and inhibitor-
treated cells were surface biotinylated. For this purpose,
the cell membrane impermeant reagent S-NHS-biotin
was added at 48 h p.i., the time point at which control
virus release was almost maximal and the inhibitor-
induced reduction of virus release was most pro-
nounced. After biotin labelling, cells were lysed and the
MV glycoproteins H and F were immunoprecipitated by
specific antibodies. Precipitates were separated by SDS-
PAGE and transferred to nitrocellulose. Biotinylated H












Figure 2 Effect of F-actin disruption and stabilization on virus release and cell-associated infectivity. MDCK cells were infected with MV at
an MOI of 10. Inhibitors were added at 12 h p.i. Supernatants were taken in 12 hour intervals to titrate cell-free virus and cells were harvested at
24, 48 and 72 h p.i. To titrate cell-associated infectivity, virus titers were quantitated by plaque assay. Values plotted represent mean results of two
independent experiments.
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protein is an intracellular protein and thus not surface
biotinylated, it was detected after immunoprecipitation
by Western blot analysis (Figure 3B). The viral N protein
and cellular tubulin and actin were directly detected in
the cell lysates by western blot analysis (Figure 3C).
Figure 3 shows no substantial differences in the protein
amounts in inhibitor-treated cells compared to control
cells. We thus conclude that neither changes in the over-
all protein expression levels, nor a decreased surface ex-
pression of the viral glycoproteins can be responsible for
the observed reduction in virus particle formation upon
actin filament disruption or stabilization.
Cytochalasin D but not Jasplakinolide treatment leads to
retention of M-RNP complexes in the cytoplasm
To further elucidate which assembly step is inhibited by
actin disruption or stabilization, we analyzed the influence
of inhibitor treatment on the intracellular localization of
the viral proteins. For this purpose, co-immunostaining of
M and H protein or M and N protein was performed. At
48 h p.i., cells were fixed and permeabilized and the pro-
teins were detected with specific primary antibodies and
AF488- (N protein) or AF568-labelled (M protein) sec-
ondary antibodies. As shown in Figure 4A, M and N pro-
teins (RNPs) colocalized almost completely in control and
inhibitor-treated cells. However, while M-RNP complexes
in control and Jaspla-treated cells were predominantly lo-
cated at the plasma membrane, the complexes accu-
mulated in the cytoplasm after CD treatment. The
intracellular localization of the proteins was confirmed by
altering the gain in the confocal image to identify the cell
limits. To corroborate the lack of M transport to the cell
surface, M-H co-staining was performed. For this, cells
were fixed and permeabilized with Triton X-100 and the
H protein was detected by an H-specific antibody andAF488-conjugated secondary antibodies. The M protein
was detected with an AF555-labelled monoclonal anti-M
antibody. Supporting the idea of a defective M-RNP trans-
port upon CD treatment, H and M colocalized markedly
in control and Jaspla-treated cells whereas M was found in
large intracellular patches in CD-treated cells (Figure 4B).
The lack of H and M colocalization is clearly seen in the
in the side view (vertical xz section) of the merged image.
This result indicates that intact actin filaments are essen-
tially required for M-RNP surface transport. Reduced virus
release upon CD treatment is therefore concluded to be
due to a defective budding as a result of a reduced amount
of viral M-RNP complexes present at the plasma mem-
brane. Interestingly, the reduced particle release upon
Jaspla treatment does not appear to be linked to a defect-
ive M-RNP transport to the plasma membrane.
Actin disruption by Cytochalasin D increases cell-to-cell
fusion
Actin disruption did not influence surface expression of
the viral glycoproteins but led to retention of M-RNP
complexes in the cytoplasm. As it is known that M
downregulates cell-to-cell fusion by interacting with the
cytoplasmic tails of the viral glycoproteins at the plasma
membrane [1-3], we wanted to assess if syncytium for-
mation of MV-infected MDCK cells is affected by the in-
hibitor treatment. Since MDCK cells do not fuse rapidly
and fusion progression might be further hindered by
cell-morphological alterations due to the inhibitor treat-
ment, fusion capacity was monitored by detaching the
infected, inhibitor-treated MDCK cells with accutase
and subsequent mixing with a Vero cell suspension.
Non-infected and non-inhibitor treated Vero cells serve
here as “fusion indicator cells”. Cell mixtures were co-
cultured for 5 h and syncytia formation was visualized









Figure 3 Viral protein expression upon F-actin disruption and
stabilization. MDCK cells were infected with MV at an MOI of 10
(control, CD, Jaspla), or left uninfected (mock). Inhibitors were added
at 12 h p.i.. At 48 h p.i., cells were surface biotinylated and
subsequently lysed in RIPA buffer. (A) To determine the amount of
MV glycoproteins expressed on the cell surface, H and F were
immunprecipitated from cell lysates with specific monoclonal
antibodies. Samples were then separated by SDS-PAGE, transferred
to nitrocellulose and probed with AF680-conjugated streptavidin.
(B) M protein was immunoprecipitated from cell lysates using an
anti-M specific antibody. Precipitates were subjected to western blot
analysis using M-specific primary antibodies and AF680-conjugated
secondary antibodies. (C) For N, tubulin and actin staining, lysates
were directly subjected to SDS-PAGE, blotted to nitrocelluose and
incubated with specific primary antibodies and fluorophore-
conjugated secondary antibodies. Blots were scanned with a Li-Cor
Odyssey IR system.
Dietzel et al. Virology Journal 2013, 10:249 Page 5 of 11
http://www.virologyj.com/content/10/1/249infected cells showed an increased fusion activity after
CD treatment. This clearly supports our idea that CD-
mediated retention of the M protein in the cytoplasm
resulted in a reduced M-glycoprotein interaction at the
plasma membrane, and thus to a reduced fusion
downregulation by M. Since it has been proposed that
actin structures can also restrict fusion-pore extension
[16,17], we wanted to rule out that the observed in-
creased syncytia formation upon CD treatment might be
simply due to the disruption of the actin cytocortex
facilitating expansion of the fusion pores. We therefore
analyzed the effect of CD treatment on MV
glycoprotein-mediated cell-to-cell fusion in the absence
of M and any virus infection. For this purpose, wecoexpressed H and F proteins in MDCK cells, incubated
the cells either in the absence or presence of CD for
18 h, and performed the fusion assay as described above.
In contrast to the infection, H and F cotransfected cells
did not show enhanced fusion capacity after CD-
mediated actin disruption. We thus conclude that the
increase of the relative fusion after CD treatment in
MV-infected cells is due to a reduced M-mediated fusion
downregulation, and is therefore the consequence of the
defective M surface transport in cells with a disrupted
actin cytoskeleton.
Actin stabilization by Jasplakinolide affects late MV
maturation steps
Jaspla treatment reduced virus release by more than 80%
without affecting viral protein synthesis or downregulating
the surface transport of viral glycoproteins and M-RNP
complexes. Thus, very late budding steps at the plasma
membrane appeared to be affected by actin stabilization.
To address this question, we performed ultrastructural
analyses of MV-infected Vero cells, in which 200 nM
Jaspla treatment resulted in reduction of virus release into
the supernatant by 83% (data not shown). For the EM ana-
lysis, MV-infected cells were treated with Jaspla at 12 h
p.i.. After fixation at 48 h p.i., cells were processed for EM
analysis. While in control cells, virus particles and bud for-
mation were abundantly found (Figure 6A), detection of
virus buds and cell-free particles was much more re-
stricted in Jaspla-treated cells (Figure 6B, 6C). RNPs were
highly concentrated and aligned at the plasma membrane.
However, budding events are rarely seen in Jaspla-treated
cells (Figure 6B, 6C, lower panels). This clearly confirms
that actin stabilization does not block delivery of M-RNP
complexes to the plasma membrane but rather prevents
the formation of viral buds and the final pinching off.
Discussion
Consistent with an earlier report using Cytochalasin B
[18], we found that CD inhibited MV replication. Actin in-
hibitors specifically seem to block late virus assembly and
budding steps, because inhibition of earlier replication
steps such as RNA synthesis would be reflected in de-
creased overall virus protein expression levels and reduced
titers of both, released virus and cell-associated infectivity.
After actin disruption by CD, M-RNP complexes were
retained in the cytoplasm implicating a role for intact actin
filaments in M-RNP transport. Consistent with M acting
as a fusion downregulator, we found an increased cell-
to-cell fusion after actin disruption due to the lack of M-
glycoprotein interaction at the plasma membrane. Similar
to actin disruption, actin stabilization by Jaspla led to de-
creased cell-free virus titers. However, the underlying mo-
lecular mechanism is clearly different. Block of actin


















Figure 4 (See legend on next page.)
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Figure 4 Effect of F-actin disruption and stabilization on viral protein distribution. MDCK cells were infected with MV at an MOI of 10. To
prevent fusion, an inhibitory peptide (FIP) was added. Inhibitors (CD, Jaspla) were added at 12 h p.i.. (A) For N and M protein co-staining, cells
were fixed and permeabilized with methanol/acetone. N was detected by a polyclonal rabbit antiserum and AF488-conjugated secondary
antibodies. M was stained using a monoclonal antibody (MAB8910) and AF568-conjugated secondary antibodies. (B) For H and M co-staining,
cells were fixed with PFA, permeabilized with Triton X-100 and H was detected with a monoclonal antibody (K83) and AF488-conjugated
secondary antibodies. Afterwards, the M protein was stained with an AF555-labelled monoclonal anti-M antibody (MAB8910). xy sections of the
merged images (merge xy) and a side view (xz) are shown. Images were recorded with a confocal laser scanning microscope (Zeiss LSM510).
Magnification 630x.
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electron microscopic observations rather indicate a defect
in bud formation and subsequent pinching-off.
Actin filaments (disrupted by CD) but not actin
treadmilling (blocked by Jaspla) are needed for transport
of M and MV nucleocapsids from the cytoplasm to the
cell surface. Yet, actin dynamics seem to play a role in
budding of mature virions at the plasma membrane.
Even if an early report in chronically MV-infected cells
had suggested that RNP but not the M transport to the
cell surface depends on intact actin filaments [19], we
and others have shown in more recent studies that M
interacts with RNPs in viral inclusions and movement of
viral RNPs to the plasma membrane occurs as co-




















Figure 5 Influence of cytochalasin D treatment on MV glycoprotein-m
an MOI of 10 in the presence of a fusion-inhibitory peptide (FIP). CD was a
non-infected and non-inhibitor-treated Vero cells at 48 h p.i.. 5 h later, sync
cotransfected in the presence of FIP with plasmids encoding the MV glyco
were washed and detached at 24 h post transfection. 5 h after mixing with
staining. In the upper panels, a syncytium is exemplarily shown. Fusion wa
panels. Error bars indicate standard error of the mean (SEM). ** P < 0.01.with the idea that actin filaments serve as tracks for
movement of M-coated RNPs to the cell surface, disrup-
tion of the actin filaments resulted in an intracellular re-
tention of both, M and RNPs. A very recent report
proposes that interaction with the cytoskeleton is medi-
ated by direct binding of F-actin to phenylalanine 50 in
the M protein [11]. The direct interaction of MV M and
actin is in line with findings for the M proteins of
Newcastle disease virus and Sendai virus [22] that also
serve as the recognition site for actin. However, it re-
mains to be elucidated if M binds directly to actin, or if
interaction is mediated via motor proteins. The latter
might be supported by our finding that Jaspla treatment
did not affect the M-RNP trafficking to the cell periph-




ediated cell-to-cell fusion. (A) MDCK cells were infected with MV at
dded at 12 h p.i., and cells were washed, detached and mixed with
ytium formation was visualized by Giemsa staining. (B) Cells were
proteins H and F. CD was added at 6 h post transfection, and cells
non-treated Vero cells, syncytia formation was visualized by Giemsa
s quantified as described in the methods and is shown in the lower
Figure 6 Effect of F-actin stabilization on MV budding. Electron microscopic analysis of ultrathin sections of MV-infected Vero cells either left
without treatment (A, control), or treated with 0.2 μM Jaspla at 12 h p.i. (B and C). White-line marked areas show accumulations of RNPs in the
cytoplasm. Black-boxed areas on upper panels are shown at higher magnifications in lower panels. Black arrows indicate RNPs inside viral
particles; white arrows indicate RNPs beneath the plasma membrane.
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would still be able to transport cargo (M-RNPs) along
stabilized actin filaments.
In contrast to many other viral matrix proteins [23],
MV M protein does not possess any known late domain
motif. Therefore budding does not depend on the cellu-
lar endosomal sorting complex required for transport
(ESCRT) machinery [24]. Given that MV M-RNPs inter-
act with the actin cytoskeleton and that the actin motor
protein Myosin Vb interacts with members of the Rab11
family [25], a mechanism of late domain independent
budding might be used by MV. The idea of a M-Rab11
interaction is indeed supported by the very recent find-
ing that apical release from polarized epithelial cells
depends on the Rab11A-dependent apical recycling
endosomal pathway [26].
Multifunctional involvement of actin microfilaments
during viral infection has been documented in many
studies. Dependence of viruses on actin, however, differs
drastically not only between different DNA and RNA
virus families, but even between closely related virus
family members. Thus, it must be concluded that each
virus has evolved its own mechanism to interact withthe cellular cytoskeleton machinery ensuring optimal
replication. In contrast to our findings, HPIV-3 needs
intact actin filaments for viral RNA synthesis [27]. Con-
sequently, actin disruption led to a reduction of HPIV-3
release due to lack of viral proteins. For the budding
process of HPIV-3, microtubules rather than actin fila-
ments are important [28]. Since Cytochalasin B had no
negative effect on VSV release, it was supposed that
actin is not involved in VSV replication [29]. However,
interaction of VSV M with dynamin was recently shown
to be required for assembly [30]. Treatment of Rotavirus
infected polarized epithelial cells with Jaspla did not re-
duce overall virus release but altered the budding polar-
ity from apical to bipolar [13]. MV is also released
apically from polarized epithelia [31-33], but actin
treadmilling does not seem to play a role in polarized
MV release since treatment of MV-infected polarized
MDCK cells with Jaspla did not alter budding polarity
(Dietzel, unpublished observation).
As in MV infection, disruption of the actin cytoskel-
eton reduced release and viral infectivity of HIV [34].
Recent cryo electron tomography studies have shown
that HIV budding at the plasma membrane can be
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actin context [35]. Even if most of the budding sites
were found adjacent to filamentous actin, only half of
them were associated with filopodia-like structures char-
acterized by a parallel actin organization. The rest of the
buds were found with cortical actin parallel to the plasma
membrane, or with cortical actin directed towards or pro-
truding into the budding site. Even if actin filaments have
been shown to protrude into budding MV particles [8,18],
one might speculate that highly pleomorphic MV particles
also bud in different forms. Though we cannot rule out
that the only partial block of virus release observed upon
Jaspla treatment is due to an incomplete stabilization of
actin filaments at the used concentrations, it might be
speculated that only budding forms that have a distinctive
requirement for actin dynamics or treadmilling are af-
fected by cytocortical actin stabilization.
Recent observations have shown that the interaction of
the MV glycoprotein complex with receptors on lympho-
cytes and dendritic cells (DCs) initiate cytoskeletal dynam-
ics. In DCs, MV binding initiates host cell cytoskeletal
dynamics needed for viral uptake and the establishment of
functional synapses with T cells. Furthermore, MV binding
to T cells causes a loss of polarization, adhesion and motil-
ity by actin cytoskeletal paralysis [36]. It is therefore highly
likely that integrity and dynamics of actin filaments not
only play an important role in virus maturation at the
plasma membrane, but are also involved in MV-mediated
immunosuppression.
Conclusion
This paper demonstrates that intact actin filaments are
required for M-RNP transport to the plasma membrane,
and are thus needed to initiate assembly at the plasma
membrane and to downregulate cell-to-cell fusion medi-
ated by surface-expressed viral glycoproteins. We fur-
thermore provide first conclusive evidence that actin
dynamics are critically required in later steps in MV




MDCK cells were cultured and infected in Minimal
Essential Medium (MEM) supplemented with 10% fetal
calf serum (FCS), Penicillin and Streptomycin. Vero cells
were maintained in Dulbecco’s MEM supplemented with
10% FCS and antibiotics. Cells were infected during
seeding with the MV Edmonston strain at an MOI of 10
(MDCK cells) or an MOI of 1 (Vero cells), respectively.
Inhibitor treatment and virus growth analysis
Inhibitor stocks were prepared in DMSO at concen-
trations of 4 mM Cytochalasin D (Sigma-Aldrich) and0.1 mM Jasplakinolide (Calbiochem), respectively. Differ-
ent dilutions of the inhibitors were assessed (1–4 μM
CD and 50–200 nM Jaspla) to determine appropriate
working concentrations that have maximal effects on the
actin cytoskeleton without causing a loss of cell viability.
In all experiments, 4 μM CD were used. Jaspla was used
in a concentration of 100 nM and 200 nM for MDCK
and Vero cells, respectively. Inhibitors were diluted to
final concentrations in cell culture medium with 2% FCS
and added to infected cells at 12 h p.i.. To prevent syn-
cytia formation in MV-infected cells, a fusion inhibitory
peptide (FIP, Bachem) was added at a concentration of
0.1 mM [37]. Cell supernatants were taken at 24, 36, 48,
60 and 72 h p.i. for plaque titration. To determine cell-
associated infectivity at 24, 48 and 72 h p.i., cells were
scraped into OptiMEM (Invitrogen). After one freeze-
thaw cycle using liquid nitrogen and a 37°C water bath,
lysates were clarified by low-speed centrifugation, and
the supernatant was used for plaque titration.
Immunofluorescence analysis
Inhibitor-treated and control cells grown on Permanox
ChamberSlides were immunostained at 48 h p.i.. To
stain filamentous actin, cells were fixed with 2% parafor-
maldehyde (PFA) in DMEM for 15 min and subsequently
permeabilized with 0.2% Triton X-100 in PBS for 10 min
at room temperature. Filamentous actin was detected
using 12.5 μg/ml Phalloidin-FITC (Sigma-Aldrich). M
and N protein costaining was performed as described
previously [5]. Briefly, cells were fixed and permeabilized
with cold methanol/acetone (1:1) for 5 min. Cells were
then incubated with a mouse monoclonal M-antibody
(MAB8910, Millipore) and an N-specific polyclonal
rabbit antiserum. Primary antibodies were detected using
AF568- or 488-coupled secondary antibodies, respect-
ively. For costaining of M and H, cell were fixed with 2%
PFA and permeabilized with 0.2% Triton X-100. H pro-
tein was detected using a monoclonal antibody from
mouse and an AF488-labeled secondary antibody. Subse-
quently, a saturation step with 5% mouse serum was
performed. To stain the M protein, the M specific
monoclonal antibody MAB8910 was labeled with AF555
using a Zenon labeling kit (Invitrogen) and added to the
cells for 60 min on ice. Finally, cells were mounted in
Mowiol and confocal fluorescence images were recorded
using a Zeiss Axioplan2 LSM510.
Surface biotinylation and western blot analysis
At 48 h p.i., infected and inhibitor-treated MDCK cells
were surface biotinylated using S-NHS-Biotin (Calbiochem)
as described earlier [3]. For actin, tubulin and MV-N stain-
ing, cell lysates were directly subjected to SDS-PAGE and
transferred to nitrocellulose. Actin and tubulin were
detected using specific mouse antibodies (Sigma-Aldrich,
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(Invitrogen, dilution 1:5000). N was detected using an
N-specific rabbit polyclonal antiserum [5] at a dilution of
1:1000, and an IRDye800-conjugated secondary anti-
body (Biomol, dilution 1:5000). Residual supernatants
were divided into three parts and used for immunopre-
cipitation of M, H and F. H was precipitated by K83 [3],
F was precipitated with an Fcyt antiserum [38], and M
was precipitated by incubation with MAB8910. After
addition of 20 μl of a suspension of protein A-sepharose
CL-4B (Sigma-Aldrich), immuncomplexes were washed
and subjected to SDS-PAGE under reducing conditions.
After blotting to nitrocellulose, M was detected using
MAB8910 and an AF680-conjugated secondary anti-
body. Immunoprecipitated and surface-biotinylated H
and F proteins were detected using Streptavidin-AF680.
Labelled proteins were detected by the Odyssey infrared-
imaging system (LI-COR).
Cell transfections
MDCK cells were grown to 80% confluency and then
cotransfected with pCG-MV H and pCG-MV F [39]
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s protocol. Inhibitors and FIP were added
in MEM 2% FCS at 6 h p.t. and cells were further incu-
bated for 18 h (24 h p.t.).
Fusion assays
MDCK cells were either infected with MV, or were
cotransfected with MV-H and F in the presence of FIP, to
prevent fusion. Inhibitors were added at the times indi-
cated. At 48 h p.i. or 24 h post transfection, cells were de-
tached by accutase (Sigma-Aldrich). Untreated Vero cells
were also detached using accutase and mixed with MDCK
cells at a ratio of 3:1 for infected, and 30:1 for transfected
MDCK cells. Cocultures were incubated in DMEM 10%
FCS for 5 h in the absence of FIP to allow fusion. Then,
cells were fixed and stained by a 1:10-diluted Giemsa
staining solution. Cell-to-cell fusion was quantified as de-
scribed previously [40] by counting and averaging the
number of nuclei of 20 randomly chosen syncytia.
Electron microscopy
MV-infected cells were fixed for ultrastructural analysis
cells by adding a 2× fixation solution containing 0.2 M
PHEM [120 mM piperazine-N,N=−bis(2-ethanesulfonic
acid) (PIPES), 50 mM HEPES, 4 mM MgCl2, 20 mM
EGTA (pH6.9)], 8% PFA and 0.2% glutaraldehyde to the
medium. After incubation for 30 min at room tem-
perature, cells were scraped off and pelleted. The super-
natant was discarded and 4% PFA in DMEM was added
to the cell pellet. Subsequently, samples were processed
as described previously [41]. Briefly, cells were postfixed
for 60 min with 1% osmium tetroxide in 50 mM HEPESbuffer (pH7.5). After washings, samples were stained
overnight in a 2% aqueous uranyl acetate solution. Then,
cells were dehydrated, and embedded in a mixture of
Epon and Araldite. Ultrathin sections of the cells were
stained with uranyl acetate and lead citrate and analyzed
by using a JEM 1400 transmission electron microscope
at 120 kV.
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